title: Novel and functional norepinephrine transporter protein variants identified in attention-deficit hyperactivity disorder.
abstract: Attention-deficit hyperactivity disorder (ADHD) is a highly heritable disorder of impaired behavioral inhibition, increased motor activity, and inattention. The norepinephrine transporter (NET, SLC6A2) represents an important candidate gene for contribution to ADHD because it regulates catecholamine extracellular and tissue concentrations and contributes to executive functions disrupted in ADHD, and NET is a target for most effective ADHD therapeutics. We identified four NET coding single nucleotide polymorphisms (SNPs) in two ADHD sample sets; two SNPs produce protein variants (T283M, V245I), one of which, T283M, is a novel variant. Examination of the maternal family members through whom the T283M mutation was transmitted, provided no additional ADHD diagnoses. Given the previous identification of a NET mutation that contributes to a familial tachycardia syndrome, we examined autonomic function to reveal in the proband the highest standing-induced increase in heart rate among the ADHD subjects examined. We measured [3H]NE and [3H]dopamine transport for T283M, V245I, and a previously identified NET variant, T283R. T283M and V245I demonstrated decreased substrate transport, as did T283R, suggesting that the T283 residue is sensitive to mutation. Identification of polymorphic sites within NET, specifically those that produce functional consequences, is one critical step in elucidating the genetic variation contributing to the heritable component of diseases such as ADHD.
authors.affiliation: Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37232, USA. maureen.hahn@vanderbilt.edu
authors.forename: Maureen K
authors.initials: MK
authors.lastname: Hahn
authors.forename: Angela
authors.initials: A
authors.lastname: Steele
authors.forename: R Steven
authors.initials: RS
authors.lastname: Couch
authors.forename: Mark A
authors.initials: MA
authors.lastname: Stein
authors.forename: Jessica J
authors.initials: JJ
authors.lastname: Krueger
mesh_terms: D000818:Animals; D001289:Attention Deficit Disorder with Hyperactivity / Q000235:genetics* / Q000503:physiopathology; D001692:Biological Transport; D002460:Cell Line; D015331:Cohort Studies; D004298:Dopamine / Q000378:metabolism; D005260:Female; D006339:Heart Rate; D006801:Humans; D008297:Male; D051379:Mice; D009154:Mutation; D009638:Norepinephrine / Q000378:metabolism; D050484:Norepinephrine Plasma Membrane Transport Proteins / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide
chemical_list: D050484:Norepinephrine Plasma Membrane Transport Proteins; C493227:SLC6A2 protein, human; D004298:Dopamine; D009638:Norepinephrine
references.citation: Biol Psychiatry. 2005 Jun 1;57(11):1313-23
references.pmid: 15950004
references.citation: Behav Neurosci. 2001 Aug;115(4):934-9
references.pmid: 11508732
references.citation: Am J Med Genet B Neuropsychiatr Genet. 2008 Dec 5;147B(8):1580-8
references.pmid: 18821566
references.citation: Mol Psychiatry. 2008 Jun;13(6):624-30
references.pmid: 17876324
references.citation: Philos Trans R Soc Lond B Biol Sci. 2009 Jan 27;364(1514):163-73
references.pmid: 18957375
references.citation: Biol Psychiatry. 1999 Nov 1;46(9):1309-20
references.pmid: 10560036
references.citation: J Neurosci. 2003 Jun 1;23(11):4470-8
references.pmid: 12805287
references.citation: Philos Trans R Soc Lond B Biol Sci. 1996 Oct 29;351(1346):1463-70; discussion 1470-1
references.pmid: 8941958
references.citation: J Am Acad Child Adolesc Psychiatry. 2004 Sep;43(9):1154-8
references.pmid: 15322419
references.citation: Nat Rev Genet. 2009 Apr;10(4):241-51
references.pmid: 19293820
references.citation: J Am Acad Child Adolesc Psychiatry. 1997 Jul;36(7):980-8
references.pmid: 9204677
references.citation: Neuropsychopharmacology. 2005 Jul;30(7):1374-82
references.pmid: 15827573
references.citation: Science. 2007 Jan 26;315(5811):525-8
references.pmid: 17185560
references.citation: J Pharmacol Exp Ther. 1998 Nov;287(2):733-43
references.pmid: 9808704
references.citation: Nature. 2005 Sep 8;437(7056):215-23
references.pmid: 16041361
references.citation: J Neurosci. 2004 Jan 14;24(2):547-53
references.pmid: 14724255
references.citation: J Psychopharmacol. 1997;11(2):151-62
references.pmid: 9208378
references.citation: Proc Natl Acad Sci U S A. 2006 Dec 12;103(50):19164-9
references.pmid: 17146058
references.citation: Am J Med Genet. 2002 Apr 8;114(3):255-9
references.pmid: 11920844
references.citation: Mol Psychiatry. 2006 Oct;11(10):934-53
references.pmid: 16894395
references.citation: Child Adolesc Psychiatr Clin N Am. 2008 Apr;17(2):459-74, xi
references.pmid: 18295156
references.citation: Am J Med Genet. 2002 Aug 8;114(6):665-6
references.pmid: 12210284
references.citation: Prog Neurobiol. 2004 Oct;74(3):167-81
references.pmid: 15556286
references.citation: J Am Acad Child Adolesc Psychiatry. 2000 Jan;39(1):49-58
references.pmid: 10638067
references.citation: Am J Med Genet B Neuropsychiatr Genet. 2005 Apr 5;134B(1):115-8
references.pmid: 15719398
references.citation: J Neurosci. 2000 Oct 15;20(20):7571-8
references.pmid: 11027216
references.citation: Clin Psychol Rev. 2006 Aug;26(4):396-432
references.pmid: 16513236
references.citation: Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13473-80
references.pmid: 8942959
references.citation: Biol Psychiatry. 1999 Jan 1;45(1):26-31
references.pmid: 9894572
references.citation: Nat Genet. 2008 Jun;40(6):695-701
references.pmid: 18509313
references.citation: Mol Psychiatry. 2003 Nov;8(11):933-6
references.pmid: 14593431
references.citation: Genes Brain Behav. 2008 Jun;7(4):487-95
references.pmid: 18081710
references.citation: Neuropharmacology. 2005 Nov;49(6):724-36
references.pmid: 16171832
references.citation: Am J Med Genet B Neuropsychiatr Genet. 2008 Dec 5;147B(8):1564-7
references.pmid: 18937296
references.citation: J Neural Transm (Vienna). 2008;115(2):323-9
references.pmid: 17994190
references.citation: Biol Psychiatry. 2007 Jun 1;61(11):1296-305
references.pmid: 17239355
references.citation: Neuropsychopharmacology. 2009 Aug;34(9):2135-42
references.pmid: 19387424
references.citation: Science. 2004 Aug 6;305(5685):869-72
references.pmid: 15297675
references.citation: Am J Med Genet. 1996 Nov 22;67(6):523-32
references.pmid: 8950409
references.citation: JAMA. 2006 Oct 4;296(13):1609-18
references.pmid: 17018806
references.citation: Pharmacogenetics. 2000 Jul;10(5):397-405
references.pmid: 10898109
references.citation: Biol Psychiatry. 2005 Jun 1;57(11):1385-90
references.pmid: 15950012
references.citation: Behav Brain Res. 2003 Nov 30;146(1-2):43-55
references.pmid: 14643458
references.citation: J Neurochem. 1995 Jul;65(1):111-6
references.pmid: 7790854
references.citation: Psychopharmacology (Berl). 2004 Jun;174(1):25-31
references.pmid: 15205875
references.citation: J Pharmacol Exp Ther. 1998 Nov;287(2):744-51
references.pmid: 9808705
references.citation: Am J Med Genet B Neuropsychiatr Genet. 2004 Jan 1;124B(1):38-40
references.pmid: 14681910
references.citation: N Engl J Med. 2000 Feb 24;342(8):541-9
references.pmid: 10684912
references.citation: Electrophoresis. 2002 May;23(10):1499-511
references.pmid: 12116161
references.citation: Am J Med Genet B Neuropsychiatr Genet. 2005 Apr 5;134B(1):67-72
references.pmid: 15717291
references.citation: J Neurochem. 2004 Feb;88(4):917-27
references.pmid: 14756813
references.citation: Arch Gen Psychiatry. 1986 Feb;43(2):114-24
references.pmid: 3947207
references.citation: J Clin Psychiatry. 2002 Dec;63(12):1140-7
references.pmid: 12523874
references.citation: Mol Pharmacol. 2005 Aug;68(2):457-66
references.pmid: 15894713
references.citation: Am J Med Genet B Neuropsychiatr Genet. 2008 Dec 5;147B(8):1392-8
references.pmid: 18988193
references.citation: Pediatrics. 2003 Nov;112(5):e404
references.pmid: 14595084
references.citation: J Neurosci. 2002 Oct 1;22(19):8771-7
references.pmid: 12351753
references.citation: Neuron. 2006 Mar 16;49(6):791-6
references.pmid: 16543127